PLSH
Panacea Life Sciences Holdings, Inc.
Price Chart
Latest Quote
$0.04
| Previous Close | $0.04 |
| Open | $0.03 |
| Day High | $0.03 |
| Day Low | $0.03 |
| Volume | 3 |
Stock Information
| Shares Outstanding | 21.22M |
| Total Debt | $21.86M |
| Cash Equivalents | $117K |
| Revenue | $2.76M |
| Net Income | $-7.67M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $743K |
| EPS (TTM) | $-0.36 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $22.33M |
| Sales | $2.76M |
| Income | $-7.67M |
| Book/sh | $-0.53 |
| Cash/sh | $0.01 |
| Employees | 40 |
Financial Ratios
| Quick Ratio | 0.02 |
| Current Ratio | 0.23 |
Returns & Margins
| ROA | -18.47% |
| Gross Margin | -139.86% |
| Operating Margin | -100.09% |
| Profit Margin | -277.51% |
Ownership
| Insider Ownership | 47.73% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/S | 0.27 |
| P/B | -0.07 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.03 |
| SMA50 | $0.03 |
| SMA200 | $0.05 |
| RSI | 50.00 |
| ATR | 0.0006 |
| Shares Float | 12.52M |
| Volatility | 2.68 |
Performance History
| Week | +4.51% |
| Month | +24.16% |
| Quarter | -22.22% |
| 6 Months | -62.85% |
| YTD | -30.00% |
| Year | -4.37% |
| 3 Years | -92.93% |
| 10 Years | -92.22% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.04 | 0 |
| 2026-06-17 | $0.04 | 17,080 |
| 2026-06-16 | $0.03 | 0 |
| 2026-06-15 | $0.03 | 0 |
| 2026-06-12 | $0.03 | 0 |
| 2026-06-11 | $0.03 | 500 |
| 2026-06-10 | $0.03 | 0 |
| 2026-06-09 | $0.03 | 1,250 |
| 2026-06-08 | $0.03 | 0 |
| 2026-06-05 | $0.03 | 0 |
| 2026-06-04 | $0.03 | 2,188 |
| 2026-06-03 | $0.04 | 0 |
| 2026-06-02 | $0.04 | 20,000 |
| 2026-06-01 | $0.04 | 5,000 |
| 2026-05-29 | $0.04 | 6,000 |
| 2026-05-28 | $0.04 | 23,187 |
| 2026-05-27 | $0.04 | 72,860 |
| 2026-05-26 | $0.03 | 18,109 |
| 2026-05-22 | $0.03 | 66,492 |
| 2026-05-21 | $0.03 | 5,900 |
| 2026-05-20 | $0.03 | 50,750 |
| 2026-05-19 | $0.03 | 9,002 |
About Panacea Life Sciences Holdings, Inc.
Panacea Life Sciences Holdings, Inc., operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals. It provides a range of products, including Nitro Kava, Kratom, hemp, VAPE products, and various beverages that focuses on promoting alternative health and wellness. The company also offers natural remedies under the PANA Health, PANA Beauty, PANA Sport, PANA Pet, PANA Pure, and PANA Life brand names. It manages retail locations and a distribution center in the Tampa, Florida. The company was incorporated in 2008 and is based in Greenwood Village, Colorado.
đ° Latest News
Income Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Revenue | |||
| Reconciled Cost Of Revenue | $1,262,979 | $1,230,508 | $1,519,049 |
| Cost Of Revenue | $1,262,979 | $1,230,508 | $1,519,049 |
| Total Revenue | $2,384,956 | $1,626,978 | $2,059,627 |
| Operating Revenue | $2,384,956 | $1,626,978 | $2,059,627 |
| Expenses | |||
| Interest Expense | $1,555,877 | $2,048,171 | $1,105,243 |
| Total Expenses | $7,931,110 | $7,279,220 | $7,600,116 |
| Other Income Expense | $-913,270 | $-1,442,171 | $1,863,333 |
| Other Non Operating Income Expenses | $178,411 | $259,781 | $236,560 |
| Net Non Operating Interest Income Expense | $-1,555,877 | $-2,048,171 | $-1,105,243 |
| Interest Expense Non Operating | $1,555,877 | $2,048,171 | $1,105,243 |
| Operating Expense | $6,668,131 | $6,048,712 | $6,081,067 |
| Other Operating Expenses | $5,211,719 | $4,955,348 | $4,562,380 |
| General And Administrative Expense | $1,456,412 | $1,093,364 | $1,518,687 |
| Income & Earnings | |||
| Net Income From Continuing Operation Net Minority Interest | $-8,015,301 | $-9,142,584 | $-4,782,399 |
| Net Interest Income | $-1,555,877 | $-2,048,171 | $-1,105,243 |
| Normalized Income | $-6,923,620 | $-7,440,632 | $-6,409,172 |
| Net Income From Continuing And Discontinued Operation | $-8,015,301 | $-9,142,584 | $-4,782,399 |
| Total Operating Income As Reported | $-5,546,154 | $-5,652,242 | $-5,937,168 |
| Net Income Common Stockholders | $-8,015,301 | $-9,142,584 | $-4,782,399 |
| Net Income | $-8,015,301 | $-9,142,584 | $-4,782,399 |
| Net Income Including Noncontrolling Interests | $-8,015,301 | $-9,142,584 | $-4,782,399 |
| Net Income Continuous Operations | $-8,015,301 | $-9,142,584 | $-4,782,399 |
| Pretax Income | $-8,015,301 | $-9,142,584 | $-4,782,399 |
| Special Income Charges | $748 | $935,337 | $458,431 |
| Operating Income | $-5,546,154 | $-5,652,242 | $-5,540,489 |
| Gross Profit | $1,121,977 | $396,470 | $540,578 |
| Per Share | |||
| Diluted EPS | $-0.48 | $-0.62 | $-0.28 |
| Basic EPS | $-0.48 | $-0.62 | $-0.28 |
| Other | |||
| Tax Effect Of Unusual Items | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,654,774 | $-3,661,370 | $-3,628,143 |
| Total Unusual Items | $-1,091,681 | $-1,701,952 | $1,626,773 |
| Total Unusual Items Excluding Goodwill | $-1,091,681 | $-1,701,952 | $1,626,773 |
| Reconciled Depreciation | $1,712,969 | $1,731,091 | $1,675,786 |
| EBITDA (Bullshit earnings) | $-4,746,455 | $-5,363,322 | $-2,001,370 |
| EBIT | $-6,459,424 | $-7,094,413 | $-3,677,156 |
| Diluted Average Shares | $16,627,458 | $14,862,077 | $16,915,706 |
| Basic Average Shares | $16,627,458 | $14,862,077 | $16,915,706 |
| Diluted NI Availto Com Stockholders | $-8,015,301 | $-9,142,584 | $-4,782,399 |
| Tax Provision | $0 | $0 | $0 |
| Other Special Charges | $-748 | $-681,546 | $-755,782 |
| Restructuring And Mergern Acquisition | $0 | $-253,791 | - |
| Gain On Sale Of Security | $-1,092,429 | $-2,637,289 | $1,168,342 |
| Selling General And Administration | $1,456,412 | $1,093,364 | $1,518,687 |
| Other Gand A | $1,456,412 | $1,093,364 | $1,518,687 |
| Gain On Sale Of Ppe | - | $0 | $-297,351 |
Balance Sheet (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Assets | |||
| Net Tangible Assets | $-11,305,904 | $-4,333,354 | $4,852,191 |
| Total Assets | $17,983,462 | $19,489,449 | $23,783,651 |
| Total Non Current Assets | $13,327,109 | $13,107,186 | $14,685,293 |
| Goodwill And Other Intangible Assets | $3,014,450 | $2,188,810 | $2,250,211 |
| Current Assets | $4,656,353 | $6,382,263 | $9,098,358 |
| Other Current Assets | $263,003 | $113,098 | $278,328 |
| Inventory | $4,013,525 | $4,448,725 | $4,264,277 |
| Receivables | $263,970 | $706,127 | $744,496 |
| Accounts Receivable | $263,970 | $206,127 | $244,496 |
| Cash Cash Equivalents And Short Term Investments | $115,855 | $1,114,313 | $3,811,257 |
| Cash And Cash Equivalents | $100,922 | $6,951 | $19,774 |
| Other Intangible Assets | - | - | $61,401 |
| Prepaid Assets | - | - | $278,328 |
| Debt | |||
| Net Debt | $15,376,601 | $13,883,487 | $10,004,225 |
| Total Debt | $21,645,325 | $18,967,917 | $14,995,424 |
| Long Term Debt And Capital Lease Obligation | $6,826,885 | $6,560,072 | $6,610,363 |
| Long Term Debt | $3,572,864 | $3,572,864 | $3,263,028 |
| Current Debt And Capital Lease Obligation | $14,818,440 | $12,407,845 | $8,385,061 |
| Current Debt | $11,904,659 | $10,317,574 | $6,760,971 |
| Other Current Borrowings | $115,000 | $346,671 | $220,005 |
| Liabilities | |||
| Total Liabilities Net Minority Interest | $26,274,916 | $21,633,993 | $16,681,249 |
| Total Non Current Liabilities Net Minority Interest | $6,826,885 | $6,560,072 | $6,610,363 |
| Current Liabilities | $19,448,031 | $15,073,921 | $10,070,886 |
| Current Notes Payable | $11,789,659 | $9,970,903 | $6,540,966 |
| Payables And Accrued Expenses | $4,629,591 | $2,666,076 | $1,685,825 |
| Equity | |||
| Common Stock Equity | $-8,292,691 | $-2,145,396 | $7,101,549 |
| Preferred Stock Equity | $1,237 | $852 | $853 |
| Total Equity Gross Minority Interest | $-8,291,454 | $-2,144,544 | $7,102,402 |
| Stockholders Equity | $-8,291,454 | $-2,144,544 | $7,102,402 |
| Retained Earnings | $-33,922,898 | $-25,907,597 | $-16,765,013 |
| Other | |||
| Ordinary Shares Number | $17,645,352 | $14,965,317 | $14,762,342 |
| Share Issued | $17,645,352 | $14,965,317 | $14,762,342 |
| Tangible Book Value | $-11,307,141 | $-4,334,206 | $4,851,338 |
| Invested Capital | $7,184,832 | $11,745,042 | $17,125,548 |
| Working Capital | $-14,791,678 | $-8,691,658 | $-972,528 |
| Capital Lease Obligations | $6,167,802 | $5,077,479 | $4,971,425 |
| Total Capitalization | $-4,718,590 | $1,428,320 | $10,365,430 |
| Additional Paid In Capital | $25,628,442 | $23,760,704 | $23,865,155 |
| Capital Stock | $3,002 | $2,349 | $2,260 |
| Common Stock | $1,765 | $1,497 | $1,407 |
| Preferred Stock | $1,237 | $852 | $853 |
| Long Term Capital Lease Obligation | $3,254,021 | $2,987,208 | $3,347,335 |
| Current Capital Lease Obligation | $2,913,781 | $2,090,271 | $1,624,090 |
| Goodwill | $3,014,450 | $2,188,810 | $2,188,810 |
| Net PPE | $10,312,659 | $10,918,376 | $12,435,082 |
| Accumulated Depreciation | $-7,235,847 | $-5,522,878 | $-3,862,313 |
| Gross PPE | $17,548,506 | $16,441,254 | $16,297,395 |
| Leases | $1,806,755 | $1,508,915 | $1,508,915 |
| Other Properties | $3,864,591 | $3,242,381 | $3,595,100 |
| Machinery Furniture Equipment | $11,784,938 | $11,597,736 | $11,101,158 |
| Land And Improvements | $92,222 | $92,222 | $92,222 |
| Properties | $0 | $0 | $0 |
| Other Inventories | $29,511 | $20,120 | $21,342 |
| Finished Goods | $1,262,674 | $1,694,574 | $1,805,779 |
| Work In Process | $1,870,978 | $1,863,501 | $1,466,763 |
| Raw Materials | $850,362 | $870,530 | $970,393 |
| Duefrom Related Parties Current | $0 | $500,000 | $500,000 |
| Other Short Term Investments | $14,933 | $1,107,362 | $3,791,483 |
| Construction In Progress | - | - | $0 |
Cash Flow Statement (Annual)
| Metric | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Free Cash Flow | |||
| Free Cash Flow | $-1,589,785 | $-2,643,383 | $-4,085,036 |
| Operating Activities | |||
| Operating Cash Flow | $-1,524,463 | $-2,399,579 | $-3,922,090 |
| Cash Flow From Continuing Operating Activities | $-1,524,463 | $-2,399,579 | $-3,922,090 |
| Operating Gains Losses | $74,999 | $-276,607 | $-618,727 |
| Investing Activities | |||
| Capital Expenditure | $-65,322 | $-243,804 | $-162,946 |
| Investing Cash Flow | $-65,322 | $-196,972 | $522,533 |
| Cash Flow From Continuing Investing Activities | $-65,322 | $-196,972 | $522,533 |
| Net Other Investing Changes | - | - | $230,296 |
| Financing Activities | |||
| Financing Cash Flow | $1,683,756 | $2,583,728 | $3,334,953 |
| Cash Flow From Continuing Financing Activities | $1,683,756 | $2,583,728 | $3,334,953 |
| Net Other Financing Charges | - | - | $243,041 |
| Other | |||
| Repayment Of Debt | $-407,075 | $-1,760,511 | $-210,556 |
| Issuance Of Debt | $2,090,831 | $4,344,239 | $3,545,509 |
| Interest Paid Supplemental Data | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 |
| End Cash Position | $100,922 | $6,951 | $19,774 |
| Beginning Cash Position | $6,951 | $19,774 | $84,379 |
| Changes In Cash | $93,971 | $-12,823 | $-64,605 |
| Net Issuance Payments Of Debt | $1,683,756 | $2,583,728 | $3,334,953 |
| Net Short Term Debt Issuance | $1,683,756 | $2,583,728 | $3,334,953 |
| Short Term Debt Payments | $-407,075 | $-1,760,511 | $-210,556 |
| Short Term Debt Issuance | $2,090,831 | $4,344,239 | $3,545,509 |
| Net Investment Purchase And Sale | $0 | $46,832 | $230,296 |
| Sale Of Investment | $0 | $46,832 | $230,296 |
| Net PPE Purchase And Sale | $-65,322 | $-243,804 | $283,080 |
| Purchase Of PPE | $-65,322 | $-243,804 | $-162,946 |
| Change In Working Capital | $3,033,529 | $1,561,112 | $632,381 |
| Change In Other Current Liabilities | $468,113 | $458,773 | $458,770 |
| Change In Payables And Accrued Expense | $1,986,613 | $1,083,188 | $1,069,668 |
| Change In Prepaid Assets | $-149,905 | $165,230 | $-250,953 |
| Change In Inventory | $297,391 | $-184,448 | $-547,910 |
| Change In Receivables | $431,317 | $38,369 | $-97,194 |
| Changes In Account Receivables | $431,317 | $38,369 | $-97,194 |
| Other Non Cash Items | $576,912 | $1,067,304 | $178,915 |
| Unrealized Gain Loss On Investment Securities | $1,092,429 | $2,660,105 | $-1,008,046 |
| Depreciation Amortization Depletion | $1,712,969 | $1,731,091 | $1,675,786 |
| Depreciation And Amortization | $1,712,969 | $1,731,091 | $1,675,786 |
| Amortization Cash Flow | $0 | $61,401 | $61,400 |
| Amortization Of Intangibles | $0 | $61,401 | $61,400 |
| Depreciation | $1,712,969 | $1,669,690 | $1,675,786 |
| Net Income From Continuing Operations | $-8,015,301 | $-9,142,584 | $-4,782,399 |
| Net Business Purchase And Sale | - | $0 | $9,157 |
| Sale Of Business | - | $0 | $9,157 |
| Sale Of PPE | - | $0 | $446,026 |
| Gain Loss On Investment Securities | - | $-22,816 | $-160,296 |
| Gain Loss On Sale Of PPE | - | $0 | $297,351 |
| Net Long Term Debt Issuance | - | - | $3,091,912 |
| Long Term Debt Payments | - | - | $-210,556 |
| Long Term Debt Issuance | - | - | $3,302,468 |